Pınar, İ. E. Et Al. 2023. Comparison of International Prognostic Indices and Validation Study for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2 , 57-65.

Pınar, İ. E., Özkocaman, V., Ersal, T., Yiğit, E., Gursoy, V., Yalçın, C., ... Orhan, B.(2023). Comparison of International Prognostic Indices and Validation Study for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2, 57-65.

Pınar, İBRAHİM Et Al. "Comparison of International Prognostic Indices and Validation Study for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era," UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2, 57-65, 2023

Pınar, İBRAHİM E. Et Al. "Comparison of International Prognostic Indices and Validation Study for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era." UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2, pp.57-65, 2023

Pınar, İ. E. Et Al. (2023) . "Comparison of International Prognostic Indices and Validation Study for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era." UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2, pp.57-65.

@article{article, author={İBRAHİM ETHEM PINAR Et Al. }, title={Comparison of International Prognostic Indices and Validation Study for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era}, journal={UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi}, year=2023, pages={57-65} }